{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:53:32Z","timestamp":1775714012235,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS107961"],"award-info":[{"award-number":["R21NS107961"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-1-0422"],"award-info":[{"award-number":["W81XWH-18-1-0422"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ncl.2020.03.005","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T22:38:54Z","timestamp":1591915134000},"page":"577-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic and Diagnostic Challenges in Myasthenia Gravis"],"prefix":"10.1016","volume":"38","author":[{"given":"Thy","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecile L.","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Emilio","family":"Supsupin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazim","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ncl.2020.03.005_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mus.20667","article-title":"Is exercise necessary with repetitive nerve stimulation in evaluating patients with suspected myasthenia gravis?","volume":"35","author":"Rubin","year":"2007","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.ncl.2020.03.005_bib2","first-page":"2776","article-title":"Repetitive nerve stimulation in myasthenia gravis--relative sensitivity of different muscles","volume":"115","author":"Costa","year":"2004","journal-title":"ClinNeurophysiol"},{"issue":"9","key":"10.1016\/j.ncl.2020.03.005_bib3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/(SICI)1097-4598(199609)19:9<1069::AID-MUS1>3.0.CO;2-Y","article-title":"AAEMminimonograph #25: single-fiber electromyography","volume":"19","author":"Sanders","year":"1996","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.ncl.2020.03.005_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mus.25229","article-title":"Diagnostic accuracy of concentric needle jitter in myasthenia: Prospective study","volume":"55","author":"C N Machado","year":"2017","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ncl.2020.03.005_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mus.24769","article-title":"Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial","volume":"53","author":"Benatar","year":"2016","journal-title":"Muscle Nerve"},{"issue":"16","key":"10.1016\/j.ncl.2020.03.005_bib6","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2014.3312","article-title":"Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial","volume":"311","author":"NORDIC\u00a0Idiopathic Intracranial Hypertension\u00a0Study Group Writing Committee","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ncl.2020.03.005_bib7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2020.03.005_bib8","first-page":"427","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J\u00a0Neurol"},{"issue":"Pt 4","key":"10.1016\/j.ncl.2020.03.005_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1107\/S1600577517006087","article-title":"Effects of temperature, mechanical motion and source positional jitter on the resolving power of beamline02B at the SSRF","volume":"24","author":"Guo","year":"2017","journal-title":"J\u00a0SynchrotronRadiat"},{"issue":"5","key":"10.1016\/j.ncl.2020.03.005_bib10","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/mus.25591","article-title":"Anti-LRP4 autoantibodies in Chinese patients with myasthenia gravis","volume":"56","author":"Li","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2020.03.005_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A\u00a0comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J\u00a0Autoimmun"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.005_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00000658-193910000-00005","article-title":"Myasthenia Gravis and Tumors of the Thymic Region: Report of a Case in Which the Tumor Was Removed","volume":"110","author":"Blalock","year":"1939","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.005_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mus.22103","article-title":"The thymus in myasthenia gravis: Site of \"innate autoimmunity\"?","volume":"44","author":"Cavalcante","year":"2011","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ncl.2020.03.005_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1474-4422(18)30392-2","article-title":"Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTXrandomised trial","volume":"18","author":"Wolfe","year":"2019","journal-title":"Lancet Neurol"},{"issue":"20","key":"10.1016\/j.ncl.2020.03.005_bib15","first-page":"2006","article-title":"Randomized Trial of Thymectomy in Myasthenia Gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.005_bib16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/mus.26404","article-title":"Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis","volume":"59","author":"Clifford","year":"2019","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.005_bib17","first-page":"1019","article-title":"Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis","volume":"262","author":"Uzawa","year":"2015","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.005_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WNO.0000000000000814","article-title":"Outcomes after transcervicalthymectomy for ocular myasthenia gravis: a retrospective cohort study with inverse probability weighting","volume":"40","author":"Hamedani","year":"2020","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.005_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.autrev.2018.07.011","article-title":"Characterization of the thymus in Lrp4 myasthenia gravis: Four cases","volume":"18","author":"Koneczny","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ncl.2020.03.005_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jneuroim.2008.07.012","article-title":"Thymoma-associated myasthenia gravis: outcome, clinical and pathological correlations in 197 patients on a 20-year experience","volume":"201-202","author":"Maggi","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.005_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1468-1331.2006.01538.x","article-title":"Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care","volume":"14","author":"Hoff","year":"2007","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2020.03.005_bib22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1212\/WNL.52.3.447","article-title":"Course and treatment of myasthenia gravis during pregnancy","volume":"52","author":"Batocchi","year":"1999","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2020.03.005_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"issue":"2","key":"10.1016\/j.ncl.2020.03.005_bib24","first-page":"355","article-title":"An update: myasthenia gravis and pregnancy","volume":"36","author":"Hamel","year":"2018","journal-title":"NeurolClin"},{"issue":"2","key":"10.1016\/j.ncl.2020.03.005_bib25","first-page":"97","article-title":"Neurological diseases in pregnancy","volume":"31","author":"Toscano","year":"2019","journal-title":"CurrOpinObstet Gynecol"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.005_bib26","first-page":"352","article-title":"Clinical follow-up of pregnancy in myasthenia gravis patients","volume":"27","author":"Ducci","year":"2017","journal-title":"NeuromusculDisord"},{"issue":"8","key":"10.1016\/j.ncl.2020.03.005_bib27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1468-1331.2009.02689.x","article-title":"No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: a nationwide population-based study","volume":"16","author":"Wen","year":"2009","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2020.03.005_bib28","first-page":"263","article-title":"The epidemiology of myasthenia gravis","volume":"12","author":"Phillips","year":"1994","journal-title":"NeurolClin"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.005_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: Executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2020.03.005_bib30","first-page":"255","article-title":"Clinical characteristics of refractory myasthenia gravis patients","volume":"86","author":"Suh","year":"2013","journal-title":"Yale J Biol Med"},{"issue":"12","key":"10.1016\/j.ncl.2020.03.005_bib31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2020.03.005_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.005_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ncl.2020.03.005_bib34","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mus.21533","article-title":"Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience","volume":"41","author":"Pasnoor","year":"2010","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.ncl.2020.03.005_bib35","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1212\/WNL.0000000000004341","article-title":"Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review","volume":"89","author":"Hehir","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.005_bib36","first-page":"826","article-title":"Myasthenia gravis: a clinical-immunological update","volume":"263","author":"Binks","year":"2016","journal-title":"J\u00a0Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2020.03.005_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.25597","article-title":"Rituximab treatment of myasthenia gravis: A systematic review","volume":"56","author":"Tandan","year":"2017","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ncl.2020.03.005_bib38","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/mus.26156","article-title":"Rituximab in refractory myasthenia gravis: Extended prospective study results","volume":"58","author":"Beecher","year":"2018","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.005_bib39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2016.4190","article-title":"Durability of the rituximab response in acetylcholine receptor autoantibody-positive myasthenia gravis","volume":"74","author":"Robeson","year":"2017","journal-title":"JAMA Neurol"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:16:55Z","timestamp":1760005015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861920300268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0733861920300268"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2020.03.005","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic and Diagnostic Challenges in Myasthenia Gravis","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2020.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}